IFP Advisors, Inc - INNOVATE BIOPHARMACEUTICLS I ownership

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 1 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$00
-100.0%
0.00%
Q1 2020$0200.0%0.00%
Q4 2019$0200.0%0.00%
Q3 2019$0
-100.0%
20
-96.2%
0.00%
Q4 2018$1,000
-75.0%
5200.0%0.00%
Q3 2018$4,000
-66.7%
5200.0%0.00%
-100.0%
Q2 2018$12,0005200.00%
Other shareholders
INNOVATE BIOPHARMACEUTICLS I shareholders Q1 2021
NameSharesValueWeighting ↓
Hillview Capital Advisors, LLC 19,610$45,0000.27%
Magnus Financial Group LLC 49,500$114,0000.03%
OXFORD ASSET MANAGEMENT LLP 142,889$330,0000.01%
GSA CAPITAL PARTNERS LLP 26,500$61,0000.01%
FIRST QUADRANT LLC/CA 23,700$55,0000.00%
Tower Research Capital LLC (TRC) 4,400$10,0000.00%
MEEDER ASSET MANAGEMENT INC 2,572$6,0000.00%
SIMPLEX TRADING, LLC 1,251$2,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 35,685$82,0000.00%
UBS Group AG 13,791$32,0000.00%
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders